Browsing Tag
Storz & Bickel
2 posts
Canopy Growth narrows losses and strengthens balance sheet in Q2 FY2026 as Canadian cannabis sales surge
Find out how Canopy Growth’s Q2 FY2026 results show rising Canadian sales, smaller losses, and a restored balance sheet.
Canopy Growth Q4 misses expectations with C$221m loss, revenue down 11%
Canopy Growth stock plunges as Q4 FY2025 losses widen. Revenue declines, U.S. risks rise. Will a medical cannabis pivot revive investor confidence?